StockWatch
·

TORRENT PHARMACEUTICALS LTD. Q1 FY26 Results

TORNTPHARMQ1 FY26 Results
Filing
MetricValue (₹ Cr)vs Q4 FY25
Revenue3.2K7.4%
Total Income3.1K6.8%
Expenditure2.4K6.7%
PBT738.0011.0%
Net Profit548.0010.0%
OPM32.47%0.70pp
NPM17.45%0.52pp
EPS16.1910.1%
View full financials

Informational and educational content only. Not investment advice.